Dr. Golshani Dev WP (throwaway)

Category: Breast Augmentation

  • Breast Augmentation: Build a Responsibility Profile Before a Consultation

    Breast Augmentation: Build a Responsibility Profile Before a Consultation

    Define the Terms Before Assigning Responsibilities

    Breast augmentation is surgery intended to increase breast size. Although people often use “breast augmentation” and “breast implants” as if they mean the same thing, they describe different things: augmentation is the procedure, while implants are prosthetic devices that may be used during it.

    That distinction matters before you decide whether to book a consultation. The first question is not simply, “Which implant should I get?” It is, “What change am I hoping to discuss, and which approach might fit that conversation?” Implant-based augmentation is one pathway, but it is not the only one. Fat transfer and a discussion of breast lift surgery may also be relevant depending on the change a person wants to explore.

    General information can help you arrive prepared to discuss those pathways. It cannot determine whether surgery is appropriate for you, select an approach, predict a visual result, or replace a clinical assessment. Your anatomy, health history, breast tissue, goals, prior procedures, reproductive plans, and tolerance for future care all belong in an individualized conversation with a qualified clinician.

    A useful starting point is to write a short description of your goal without naming a solution: for example, whether you want to discuss added volume, a change in shape, concerns about breast position, or more than one of these. That keeps the consultation centered on the change you want to understand rather than on a device or procedure chosen before the assessment.

    Map the Responsibilities Attached to Each Discussion Pathway

    Use these categories to identify terms that need explanation, not to select a procedure for yourself. A clinical consultation is where their different purposes, trade-offs, and responsibilities can be discussed in relation to your situation.

    Pathway to discuss What it involves Questions and boundaries to carry forward
    Implant-based augmentation In implant-based augmentation, implants are placed under breast tissue or chest muscles. Implant options are commonly described as silicone or saline. Ask how the proposed device, placement, incision, risks, breast screening communication, and long-term follow-up relate to your goals. Implant-specific responsibilities should be part of the decision from the outset.
    Fat transfer Augmentation may also be performed with fat transfer, using fat taken from the body and injected into the breasts. Ask what this method is intended to address in your individual situation and what trade-offs the clinician considers relevant. Do not assume it is interchangeable with implant-based augmentation simply because both are forms of augmentation.
    Breast lift discussion A breast lift is distinct from implant augmentation: it reshapes existing breast tissue and does not itself use implants. If breast position or sagging is part of your concern, ask whether a lift should be discussed alongside or instead of augmentation. Implants do not prevent breast sagging. A clinician may discuss a lift in addition to augmentation after an individual assessment.

    The practical takeaway is that “more volume,” “more upper fullness,” and “a breast position concern” are not automatically the same problem. Rather than treating implants and fat transfer as competing answers, use the consultation to identify the responsibilities and unanswered questions each pathway introduces. A lift has a separate purpose from implant augmentation. Bringing those distinctions into the consultation helps prevent a narrow conversation in which the method is assumed before the goal is clear.

    If you are unsure which pathway applies, that uncertainty is itself worth bringing forward. State what you notice, what you hope to change, and what you do not want to assume. The clinician’s role is to assess the relevant options; your role is to make sure the discussion addresses the questions that matter to you.

    A mindmap showing three breast augmentation discussion pathways: implant-based augmentation, fat transfer, and breast lift discussion.
    Breast augmentation can lead to different consultation pathways, each with its own questions and trade-offs.

    Build a Breast Augmentation Responsibility Profile

    Use this as a responsibility-routing profile, not as a candidacy checklist or a way to compare yourself with another patient. Instead of ranking pathways or predicting an outcome, place each question in the lane that can answer it: general information, individualized clinical planning, or implant-specific device information. Then connect the unresolved questions to the pathway that creates them. The purpose is to prevent a general fact, a device document, or a personal clinical decision from being treated as interchangeable.

    1. Name the question before naming the pathway. Write the change you want to discuss in ordinary language, such as volume, shape, position, or asymmetry. Then create three notes for it: what general information can clarify, what requires individualized clinical planning, and what device information would matter if implants enter the discussion.

    2. Separate the pathways. Keep implant-based augmentation, fat transfer, and a lift discussion in separate entries. For implants, the profile must include device information and long-term care; for fat transfer, it must include the separate questions created by using fat taken from another body area; for a lift, it must preserve the distinction between position and implant-based volume.

    3. Mark plan-dependent responsibilities. Record the incision, placement, and anesthesia questions only as items for clinical explanation. General descriptions can show what needs discussion but cannot establish a plan for you.

    4. Attach device duties only where they belong. If implants are under consideration, add patient-labeling materials, implant-specific complications, breast-screening communication, and the possibility of future procedures. Breast implants are not lifetime devices, and future surgery may be needed for reasons including rupture or changes in the breasts or body.

    5. Record life considerations separately. Keep breastfeeding questions and practical recovery-support questions distinct from device information. Breastfeeding after augmentation is possible for some people but can be challenging for others.

    6. Test the routing, not just the list. Ask whether each entry is assigned to the right answer source: general explanation, clinician discussion, or approved device labeling. If travel or distance could affect care, place continuity and follow-up questions in the clinician-discussion lane rather than assuming an arrangement.

    7. Set a discussion boundary. End with the responsibility you would need explained before deciding whether to continue exploring that pathway. An unresolved material responsibility is a reason to seek clarification, not a conclusion about suitability.

    This profile does not tell you which option to choose. It helps you test whether you understand the terms, uncertainties, and responsibilities well enough to have a more informed clinical conversation. Signed documentation alone may not establish understanding; ask for clarification when you cannot explain a material point in your own words.

    Reserve Surgical-Plan Choices for Individual Explanation

    It is tempting to turn procedural details into preferences before meeting a clinician. In practice, they are planning questions. The cited clinical source lists incision locations at the breast crease, under the arm, and around the nipple. It also notes that anesthesia planning varies: local anesthesia may be used, while general anesthesia is often used.

    Those facts are useful because they show that breast augmentation is not a single, standardized sequence of choices. They are not a basis for choosing an incision or anesthesia plan for yourself. The relevant decision depends on the procedure being discussed and on individual clinical planning.

    Use the consultation to ask direct, bounded questions: Which incision locations are being considered in my case? What factors are shaping that discussion? What anesthesia approach is planned, and who will explain its role? What should I understand about the surgical plan before consenting? Ask for explanations in language you can repeat back. A clear answer should help you understand the proposed plan and its rationale, not merely give you a term to search online.

    It is also reasonable to pause if a material choice remains unclear. Elective surgery allows room to seek clarification, review information, and decide whether you understand the proposed approach well enough to proceed.

    Add Implant-Specific Safety Responsibilities to the Profile

    For someone considering implant-based augmentation, safety is not a short disclosure at the end of the consultation. It is part of deciding whether the pathway fits your priorities. In the United States, the FDA lists breast pain, changes in nipple or breast sensation, additional surgery, capsular contracture, rupture or deflation, and possible breastfeeding impact among implant risks and complications.

    Some terms deserve plain-language discussion. FDA defines capsular contracture as tightening of tissue around an implant that can cause firmness or hardening and, when severe, squeeze the implant. FDA defines rupture as a tear or hole in an implant’s outer shell. FDA states that severe capsular contracture may require reoperation and can recur after corrective surgery.

    The FDA also identifies BIA-ALCL, a type of non-Hodgkin lymphoma, among breast-implant-associated risks. It lists reports of squamous cell carcinoma, lymphomas other than BIA-ALCL, and mesenchymal tumors including sarcoma among breast-implant concerns. These are consequential topics to review carefully in a device-specific conversation; they should not be minimized, generalized into a prediction about an individual, or treated as a reason to skip informed discussion.

    Long-term planning also includes the possibility of later procedures.

    FDA directs readers to approved implant patient labeling for complete complication lists and rates. Ask for the patient labeling for any implant under discussion and review it before making a final decision. In 2021, FDA strengthened breast-implant risk-communication requirements, including sales and distribution restrictions intended to support informed decisions.

    A productive consultation question is not “Will I need another surgery?” because no one can promise a personal answer. Ask instead: “What future procedures might become relevant, what circumstances could lead to them, and what does the device labeling say about complications and rates?” That question keeps uncertainty visible without converting it into either reassurance or alarm.

    Keep Variable Implant Lifespan and Consent Questions Visible

    Do not treat an implant as a lifetime purchase with a fixed expiration date. Available clinical information gives different typical estimates—about 10 years in one source and about 10–15 years for possible replacement or revision in another—so implant lifespan should be treated as variable rather than fixed. The same source notes that rupture and changes in the breasts or body can lead to further surgery. The more useful planning stance is to understand that implant-based augmentation can involve long-term attention and that future decisions may be necessary.

    Meaningful consent is more than signing a form. The cited informed-consent article describes inconsistency in cosmetic-surgery consent practices and cautions that signed documentation alone may not establish understanding. If you cannot explain the proposed procedure, alternatives, material risks, expected follow-up, and future-care responsibilities in your own words, ask for a slower explanation.

    In one international respondent survey, 63.2% reported two face-to-face consultations with physical examination before cosmetic surgery, while 31.2% reported one. This describes respondents’ practices, not a universal requirement. Likewise, most respondents believed the performing surgeon should be responsible for consent and postoperative management, including in surgical-tourism cases; that is a survey finding rather than a universal legal or clinical standard.

    For a reader, the practical lesson is straightforward: prioritize continuity, clarity, and enough time to consider what you have learned. If travel is part of your plan, ask specifically who handles postoperative management, how follow-up is arranged, and what information should travel with you. Do not rely on an online exchange alone to settle questions that require physical examination and individualized planning.

    Turn the Responsibility Profile Into a Consultation Agenda

    Before scheduling or after a consultation, use a short written routing agenda organized by answer source and pathway. You do not need to know the answers in advance. Its purpose is to show which points belong in general education, which require individualized explanation, which should be checked against implant labeling, and which pathway-specific responsibilities remain unresolved.

    • What change do I want to discuss, and what responsibility might that discussion introduce without selecting a procedure in advance?
    • Which pathway is being discussed—implant-based augmentation, fat transfer, or a lift—and what purpose does each term describe?
    • If implants are under consideration, what device information and patient labeling should I review?
    • Which responsibilities belong specifically to the implant, including capsular contracture, rupture or deflation, sensation changes, breast screening communication, and possible additional surgery?
    • What questions about fat transfer or a lift should remain separate from implant responsibilities?
    • Which incision, placement, and anesthesia choices require an individualized explanation?
    • What recovery-support, follow-up, and continuity questions remain unanswered?
    • What future revision or removal possibilities should I understand without treating them as a prediction?
    • Which responsibility would I need explained before deciding whether to continue exploring this pathway?

    A useful consultation should help you complete your responsibility profile by showing which pathway is being discussed, what responsibilities it creates, and which questions remain individualized. Take time to review device information when implants are discussed, keep alternatives distinct, and pause when you cannot explain a material part of the proposed plan to your satisfaction.


    Frequently Asked Questions About Breast Augmentation Responsibilities

    What is the difference between breast augmentation and breast implants?

    Augmentation is the procedure intended to increase breast size, while implants are the prosthetic devices often used in that procedure. The terms are often used together, but they are not the same thing.

    What options are usually discussed besides implant-based augmentation?

    Fat transfer and a breast lift may also come up, depending on the change you want to discuss. Each pathway has different trade-offs, so it helps to clarify whether your main concern is volume, shape, position, or more than one of these.

    What should I ask about implant safety if implants are part of the discussion?

    Ask about the risks and complications that are most relevant to the specific device and plan being discussed, including capsular contracture, rupture or deflation, sensation changes, and the possibility of additional surgery. It is also reasonable to ask for the patient labeling and to review it before deciding.

    Will implants stop breast sagging?

    No. Implants do not prevent sagging. If breast position is part of your concern, a clinician may discuss whether a lift should be considered along with or instead of augmentation after an individual assessment.

    What long-term issues should I bring up if I am considering surgery?

    Plan to discuss breast screening, possible future procedures, and any breastfeeding concerns that matter to you. Breast implants may require additional mammographic views, and future surgery can become relevant if the implant or breast changes over time.


  • Breast Augmentation: How to Read Procedure, Device, and Outcome Information Before a Consultation

    Breast Augmentation: How to Read Procedure, Device, and Outcome Information Before a Consultation

    Start With What Each Source Can Actually Establish

    Breast augmentation information comes from different kinds of sources, and each source answers a different kind of question. A procedure description can define terms. FDA materials can identify device-specific responsibilities and risks. Research can describe findings across groups. None of those sources can determine whether a procedure is appropriate for you.

    This guide focuses on how to read that information before deciding whether to seek a consultation. The central question is not which source sounds most reassuring. It is what the source can establish, what it cannot establish, and which questions still need individualized discussion.

    Breast augmentation is a broad procedure category, not a synonym for breast implants. It can use breast implants or fat transfer to increase breast size, and it is also known as augmentation mammoplasty. When a person’s own fat is used to add breast volume, the procedure is called fat-transfer breast augmentation.

    As you encounter a claim, identify its source type before relying on it:

    1. Procedure background defines a treatment category or describes what it involves.
    2. Device and regulatory material addresses the particular responsibilities and risk information associated with implants.
    3. Research evidence reports patterns in studied groups, not an individual forecast.
    4. Clinical discussion is where health history, examination findings, anatomy, and personal priorities can be considered together.

    Keeping those roles distinct helps prevent a general statement from becoming a personal conclusion. It also keeps “breast implants” in its proper place: one possible approach within breast augmentation, rather than another name for every augmentation procedure.

    Read Goal Statements and Procedure Limits Separately

    A statement about what breast augmentation may address is useful background, but it is not evidence that it will address every concern a reader has. Potential goals discussed for breast augmentation can include restoring volume after weight reduction or pregnancy, changing breast shape, or addressing natural size asymmetry. Read those as examples of topics for discussion, not as promised results.

    It is equally important to notice when a source states a limit. Breast augmentation alone does not correct severe breast drooping. That tells readers that volume and breast position are not interchangeable questions. It does not establish what combination of procedures, if any, belongs in an individual plan.

    When reviewing a website, article, or image, test the claim with three questions:

    • Does it describe a general purpose of augmentation, or does it imply an outcome for a particular person?
    • Does it identify a limitation as clearly as it identifies a possible benefit?
    • Does it explain whether the issue being discussed is volume, shape, asymmetry, position, or more than one of these?

    Reference images can help someone describe a visible feature, but they do not establish a personal result. If an image is useful, use it to name the feature you want to ask about rather than as proof that the same appearance can be achieved. A responsible source leaves room for anatomy, examination findings, and professional judgment rather than presenting an appearance concern as though it has one automatic solution.

    This approach preserves the value of general information without asking it to settle a clinical question it cannot answer.

    Compare Procedure Descriptions Without Treating Them as Selection Advice

    Procedure descriptions are most useful when they explain what a label means without implying that the label selects itself. Implant-based augmentation and fat-transfer augmentation involve different background information, but neither description determines which approach is appropriate for a particular person.

    Information to check Implant-based augmentation Fat-transfer augmentation
    What the label establishes In the United States, FDA-approved breast implants for sale are saline-filled or silicone gel-filled. Both types have a silicone outer shell and vary in size, shell thickness, surface texture, and shape. Fat-transfer augmentation uses liposuction to collect fat from elsewhere in the body for injection into the breasts.
    What the label does not establish A device category does not determine whether a specific device or surgical plan fits an individual’s anatomy, health history, or goals. A description of the process does not determine whether a person is suitable for a two-area procedure.
    What needs further explanation The relevant labeling, risks, monitoring, and potential future device responsibilities. The questions raised by both the donor area and the breast-volume discussion.

    ASPS describes fat transfer as an option often discussed for relatively small increases in size. That is a description of the context in which it may be discussed, not a recommendation or a prediction of an individual result.

    A useful source comparison does not rank these pathways. Instead, it makes clear whether the material is defining a procedure, describing an FDA-regulated device, or making a claim that depends on individual evaluation. If a source moves quickly from a broad description to a conclusion about what you should choose, treat that conclusion as a question to examine in a consultation rather than as settled information.

    Recognize When General Material Reaches Its Limit

    General educational material has a clear boundary: it cannot combine your health information and anatomy into a surgical conclusion. A breast-augmentation consultation may review general health, pre-existing conditions and risk factors, breast anatomy and measurements, options, likely outcomes, and potential complications. Those are not details an online article can evaluate for an individual reader.

    This is a useful standard for judging the limits of a source. Reliable general information can help you recognize which categories belong in a consultation, but it should not tell you that a medication, prior procedure, body feature, or future plan makes an approach right or wrong for you.

    Before a visit, prepare a factual account of relevant medical history, prior breast procedures, medications or supplements, and future considerations that matter to you. The purpose is not to self-screen. It is to make sure the clinician has the information needed for an individualized discussion.

    If breastfeeding is a future consideration, ask about potential implant-related impacts. The FDA identifies possible impacts on breastfeeding among the issues to consider with breast implants. That statement is not a prediction about an individual’s ability to breastfeed.

    A source is being appropriately cautious when it distinguishes background information from the evaluation needed to apply it. Look for that distinction whenever a claim refers to anatomy, health history, likely outcomes, or personal suitability.

    Read Research Findings as Context, Not a Personal Prediction

    Research can add useful context to an augmentation discussion, but study findings need to be read at the level they were produced. They describe results in groups under particular study conditions; they do not predict satisfaction, well-being, or complications for one reader.

    One systematic review and meta-analysis synthesized 39 studies involving 18,322 patients. It found improvements in several patient-reported outcomes on average, including satisfaction with breasts and psychosocial and sexual well-being. Physical well-being findings were mixed and varied by technique and follow-up. The appropriate takeaway is neither that benefits are assured nor that research is irrelevant. It is that favorable average findings coexist with variation and uncertainty.

    A multicenter observational study reached a related limit: measured preoperative patient, anatomy, and implant-related factors explained only a limited share of variation in satisfaction at six months. That finding is a reason to avoid treating a checklist of preoperative traits as a personal forecast.

    Regulatory risk information should be read with the same care. For implant-based augmentation, FDA-listed risks include pain or changes in nipple or breast sensation, capsular contracture, rupture or deflation, and possible additional surgery or removal. These are recognized risk categories, not a way to calculate a reader’s personal likelihood of experiencing them.

    For device-specific complication lists and rates, consult the patient labeling for the particular approved implant under consideration. The FDA directs readers to those materials because risk information is tied to a particular device, not to a general idea of implants. A source that names a risk while omitting its device-specific context may be incomplete; a source that turns a group result into an individual promise goes beyond what the evidence can support.

    Use FDA Device Materials for Long-Term Implant Questions

    Implant information should be read as long-term device information, not merely as a description of surgery day. FDA labeling recommendations for saline and silicone gel-filled implants include a patient decision checklist and patient device card information. These materials are valuable because they connect a proposed device to its warnings, information, and ongoing responsibilities.

    If implants are being considered, ask to review the implant labeling, including the patient decision checklist and device card information. Keep the manufacturer and model information for an implant, such as the information provided on a patient device card. Retaining that information supports later conversations about the device.

    The FDA advises that implant discussions include goals and expectations, benefits and risks, monitoring for complications for as long as implants are present, and the possibility of eventual removal or replacement. This framing is important when assessing promotional material: a complete explanation should not describe an implant only in terms of an immediate appearance goal while leaving out continuing responsibilities.

    BIA-ALCL is a T-cell lymphoma that can develop following breast implants. FDA states that it appears more often in patients with textured implants and that most cases occur years after placement and present with changes around the implant. Persistent swelling, a mass, or pain around an implant warrants discussion with a healthcare provider for evaluation. For people without symptoms, FDA does not recommend removal solely over BIA-ALCL concern; individual concerns should be discussed with a healthcare professional.

    Recovery instructions require individualized guidance from the clinical team. General online material should not be treated as a personal timetable, activity clearance, or substitute for procedure-specific instructions. Keep recovery questions separate from the device materials so that neither is mistaken for the other.

    Use What You Learned to Prepare a Focused Consultation

    A consultation is the place to test whether the information you found is complete, applicable, and clearly explained. Bring the sources or claims that influenced your thinking, especially any that seemed to promise a result, minimize a limitation, or make a device choice sound automatic.

    Use the conversation to ask what a statement actually refers to. Is it a general procedure definition, a device-specific labeling point, a research finding across groups, or an explanation based on your own health history and examination? That distinction can clarify why a persuasive online claim may still be insufficient for a decision.

    ASPS recommends selecting a board-certified plastic surgeon and suggests considering an ASPS member. A consultation may review health history and risk factors, breast anatomy and measurements, options, likely outcomes, and potential complications. Use the consultation to ask questions and document answers.

    Useful questions include:

    • Which statements from the materials I reviewed apply generally, and which require individualized interpretation?
    • If implants are discussed, which labeling and device records should I review and retain?
    • What limitations, risks, follow-up responsibilities, and possible future procedures need explanation before I decide whether to continue?
    • Which unanswered questions depend on examination findings or other clinical information?

    You may decide to pause after the visit if important information remains unclear. The goal is not to collect more claims than you can assess; it is to leave with a clearer understanding of the evidence, the limits of general information, and the questions that need professional evaluation.

    Frequently Asked Questions About Sorting Breast Augmentation Information

    What is the difference between breast augmentation and breast implants?

    Breast augmentation is the broader procedure category. It can be done with implants or with fat transfer, while breast implants are one option within that category.

    How can I tell whether a proposed approach has been explained clearly?

    Ask what concern it is intended to address, what general information supports discussing it, what still requires individual evaluation, and what commitments or limitations come with it. A clear explanation should distinguish those categories.

    What should I review if implants are being discussed?

    Review the specific implant type and its labeling, including the patient decision checklist and device card information. Discuss the main risks, how follow-up works over time, what changes warrant evaluation, and which device records to retain.

    How do saline and silicone gel implants differ in a consultation?

    Both are FDA-approved implant types in the United States and both have a silicone outer shell. A consultation may also cover size, shell thickness, surface texture, and shape in relation to the goals and anatomy being evaluated.

    Can research predict whether I will be satisfied after breast augmentation?

    No. A meta-analysis found improvements in several patient-reported outcomes on average, but those findings do not predict an individual experience. An observational study also found that measured preoperative factors explained only a limited share of variation in satisfaction at six months.

    What should I do if I still do not understand why an option was raised?

    Ask for the reasoning in plain language and request that the explanation connect your stated concern, the information considered, the limits of the option, and the responsibilities involved. General information cannot replace an individualized clinical explanation.

  • Breast Augmentation: How to Review Implant Labeling Before a Consultation

    Breast Augmentation: How to Review Implant Labeling Before a Consultation

    Start With an Implant-Labeling Review Record

    Before a consultation, use the implant materials as a document-audit set rather than as a general procedure summary. Breast augmentation is intended to increase breast size, and implant-based augmentation involves placing implants under breast tissue or chest muscles. The audit question is narrower: can you identify what the materials say about the proposed device, what each document is for, and which terms still need clarification?

    Collect the benefit-and-risk labeling, boxed warning information, patient decision checklist, manufacturer patient labeling, and device card for the implant under discussion. Mark each document’s title, device details, warnings, risks, and unresolved terms. The FDA states that breast implants are not lifetime devices, so the record should also show where the materials address monitoring and the possibility of additional procedures.

    Do not use the documents to select an implant, placement, incision, or surgical plan on your own. Use them to make the later discussion more precise and to distinguish information that is device-specific from decisions that require an individualized clinical assessment.

    Record What Labeling Cannot Choose for You

    A labeling record should include a clearly marked section called “questions the materials cannot answer.” Device information can describe an implant, but it cannot establish whether a particular surgical plan fits an individual.

    Implant insertion and positioning are individualized based on factors such as implant type, the degree of enlargement desired, body type, and the surgeon’s recommendations. Potential incision locations include the areolar edge, the fold under the breast, and the armpit. These are discussion topics, not options to select from a general article. The American Society of Plastic Surgeons notes that a belly-button approach is associated with a higher complication rate.

    Write your own questions beside, rather than inside, the device materials:

    • What change am I hoping to discuss?
    • Which implant characteristics, placement, and incision are being considered, and why?
    • What features of my anatomy need professional assessment?
    • What would the proposed approach not change?

    Also separate volume from breast position. Implants do not prevent breast sagging, so a lift may be discussed when sagging is a concern. Whether augmentation alone addresses a particular concern cannot be settled by a label, photograph, or another person’s experience.

    Use Your Goals to Read Benefits and Limits Carefully

    Before reading a proposed implant’s materials, add a short statement of what you want to discuss. Breast augmentation is intended to increase breast size, but that general purpose does not establish that every appearance concern will be addressed.

    Use a second note headed “limits that matter to me.” For example, breast implants do not stop breast sagging, and changes in the breasts and body over time can affect appearance. If position is an important concern, record it as a topic for individualized assessment rather than assuming added volume will resolve it.

    Future breastfeeding priorities also belong in this note. Breast augmentation can affect nerves and ducts involved in lactation. Cleveland Clinic notes that implant placement and incision location can matter for future milk production. This does not predict an individual experience; it identifies a priority that should be raised before a plan is selected.

    This part of the record helps distinguish a hoped-for change from questions that need clinical explanation. It is a way to read benefit information carefully, not a way to forecast a personal result.

    Build the Record From Required Implant Materials

    Audit Each Document Against the Others

    Start with the benefit-and-risk labeling and boxed warning. Record the proposed device’s identifying details and copy the main benefits, warnings, risks, and limitations into separate notes. Do not combine a general implant statement with a device-specific statement unless the materials support that connection.

    Next, review the patient decision checklist. Under FDA requirements, the checklist is reviewed with the prospective patient and signed by the patient and implanting physician. Mark each topic that is clear and each term that needs explanation. The checklist is an informed-discussion document, not a personal risk calculation.

    Then compare the manufacturer’s patient labeling and educational materials with the earlier notes. Look for information that adds detail, narrows a statement, or identifies a device-specific qualification. If a term appears inconsistent or unclear, preserve both references in the record and bring the discrepancy to the surgeon rather than resolving it yourself.

    Finally, record what the device card identifies, including the implant’s serial or lot number and style and size. Keep the card with the reviewed labeling so the device information remains accessible later. The FDA advises reading the manufacturer’s materials and discussing questions with the surgeon before deciding.

    A completed audit should answer three limited questions: which documents were reviewed, which statements appear to describe the proposed device, and which points require clarification. It should not become a substitute for examination or an individualized surgical plan.

    Add Device Risks to the Record Without Self-Calculating

    FDA approval reflects testing for reasonable assurance of safety and effectiveness; it does not eliminate implant risks. Your individual likelihood of a complication cannot be determined from an article, but the known categories should be part of the decision before surgery.

    The FDA identifies capsular contracture, reoperation, and implant removal among the most common local complications and adverse outcomes. It also identifies rupture or deflation, wrinkling, asymmetry, scarring, pain, and infection at the incision site. For silicone gel-filled implants, rupture can be silent, meaning it may occur without symptoms.

    Some risks may require further evaluation or treatment. The FDA describes breast implant-associated anaplastic large cell lymphoma, or BIA-ALCL, as a risk associated with implants that can occur in the breast or surrounding scar capsule; it is not breast cancer. The FDA also says that cases of squamous cell carcinoma and various lymphomas in the capsule around implants may be rare.

    These facts do not tell you what will happen in your case. They do establish why informed consent should be more than a general statement that surgery has risks. Ask for an explanation of the risks associated with the proposed implant, what symptoms or changes should prompt contact, and what further evaluation or treatment could be considered if a complication occurs.

    A reasonable decision does not require pretending that risks are absent. It requires understanding which risks are known, which questions remain individualized, and whether you are prepared to accept the possibility of additional care.

    One way to keep this discussion useful is to separate three kinds of questions. First, ask which complications and warnings are identified in the labeling for the specific device under consideration. Second, ask what changes or symptoms the treating team would want you to report and what evaluation may follow. Third, ask which aspects of your health history, anatomy, and proposed plan still need individualized assessment. This separation matters because a general risk list can identify subjects for discussion, but it cannot predict whether a complication will occur for you or determine how a clinician would manage it.

    If an explanation leaves you unsure whether a point is a known device risk, a monitoring issue, or an individualized concern, write it down for clarification before making a decision. Understanding the category of a question can make manufacturer materials and the patient decision checklist more useful without turning them into a personal risk calculation.

    Record the Follow-Up Responsibilities Attached to a Device

    The device card and follow-up information should form the long-term section of the review record. The FDA states that breast implants require monitoring for as long as they remain in place, and that the likelihood of complications and adverse outcomes rises the longer implants are in place.

    For silicone gel-filled implants, a clinician may recommend periodic MRI or ultrasound screening for rupture and other complications. Record the questions you need answered about the proposed device: what monitoring may be considered, when it may be considered, who will explain the plan, and how the plan will be documented.

    The device card contains information specific to an implant, including its serial or lot number and style and size. Keep it with the labeling and postoperative information so the information remains accessible later. The FDA advises promptly contacting a surgeon or health care provider about abnormal changes in the breasts or implants.

    A completed record does not supply a universal follow-up schedule. It helps you recognize that device information remains relevant after surgery and gives you a focused list for a clinician-led follow-up discussion.

    Keep Recovery Questions Separate From Device Information

    Keep recovery logistics in a separate section of the record rather than treating them as device-labeling details. Preparation may include testing, medication review or adjustments, smoking cessation, and avoiding certain substances as directed by the surgical team. Do not make medication or substance changes from a general checklist alone.

    After surgery, support may include gauze dressings and an elastic bandage or support bra. Instructions vary, including directions about support garments and incision care. The treating plastic surgeon’s specific postoperative instructions are the directions to follow.

    Use this page to capture practical questions for a consultation:

    • Which preparation steps would need to be discussed in light of my medical history and current medications?
    • What garment use, incision care, support, and activity questions should I ask about?
    • What follow-up arrangements would be relevant to the proposed plan?
    • Whom should I contact if I have a recovery question?

    This is not a recovery schedule or a promise about healing. It is a way to determine whether you understand the practical responsibilities that would accompany an individualized surgical plan.

    Use the Completed Record to Decide Whether to Seek Discussion

    Use the Audit to Prepare a Focused Discussion

    Bring the reviewed documents and a short discrepancy list to a consultation. Ask which labeling applies to the implant being discussed, how the patient decision checklist will be reviewed, what the boxed warning means in this context, and what information the device card will contain.

    Also mark questions that the documents cannot answer, including how your goals and anatomy affect the proposed plan, what placement or incision options may be considered, how recovery instructions would be individualized, and what monitoring or future procedures may need discussion. The American Society of Plastic Surgeons identifies asking whether a surgeon is certified by the American Board of Plastic Surgery as an important consultation question.

    The purpose of this audit is not to produce a recommendation. It is to make the source documents easier to compare and the unresolved questions easier to explain. If you want an individualized discussion of the audited materials and your goals, move from general education to a personalized assessment.


    Breast Augmentation Consultation FAQ

    How is the implant plan chosen?

    The choice depends on factors like the amount of enlargement desired, body type, implant characteristics, and the surgeon’s recommendations. A consultation is where placement and incision options are discussed in relation to your goals.

    What should I know if I want to breastfeed in the future?

    Mention that early in the discussion. Augmentation can affect the nerves and ducts involved in lactation, and implant placement and incision location may matter, so this priority should be reviewed before a plan is selected.

    What are the main risks to discuss before deciding?

    Some silicone implant ruptures can happen without symptoms, so risks should be reviewed carefully.

    Do breast implants need long-term follow-up?

    Yes. Discuss the follow-up plan for the device being considered with the surgeon.

    What should I expect during recovery planning?

    Preparation may include testing, medication review or adjustments, smoking cessation, and avoiding certain substances if directed by the surgical team. After surgery, you may be instructed to use a support garment and follow specific incision-care directions.

    What questions are useful to bring to a consultation?

    Ask which implant is being proposed, what labeling materials you should read, what the device card will show, how the decision checklist will be reviewed, whether the plan addresses sagging or breastfeeding goals, and what follow-up or monitoring may be needed.


  • Breast Augmentation in Beverly Hills: A Decision Path for Volume, Position, and Implant Responsibility

    Breast Augmentation in Beverly Hills: A Decision Path for Volume, Position, and Implant Responsibility

    Start With the Question You Want Surgery to Answer

    Breast augmentation is elective surgery that uses implants or, less commonly, fat transfer to enhance breast size. For many people, the more useful starting point is not “Which implant should I choose?” but “What change am I hoping to see in my proportions, clothing fit, or breast volume?”

    That distinction matters because implant selection is only one part of an individualized treatment plan. A thoughtful discussion connects your goals with your existing breast shape, tissue coverage, skin quality, symmetry, lifestyle, recovery needs, and willingness to manage an implant over time—what would you want surgery to answer for you?

    Natural-looking results can be a planning goal, not a promise. Open discussion of your motivation, expectations, and concerns can help you and a surgeon decide whether surgery is appropriate, while realistic expectations matter because an outcome may not fully match every imagined goal—are you ready to describe both what you hope will change and what you want to preserve?

    If you are also considering facial rejuvenation, body contouring, or med spa care, keep those topics separate from your breast augmentation goals—would separating these priorities make the discussion clearer?

    If surgeon credentials or travel access matter to you, ask directly whether the clinician is a double board-certified plastic surgeon and confirm whether a virtual consultation or Destination Surgery applies to your circumstances—what details would you want verified before scheduling?

    Decision One: Is Added Volume the Change You Want to Evaluate?

    The first decision is whether added volume is the change you want to evaluate. Breast augmentation is designed to add volume, while a lift may be discussed when significant sagging is present because implants alone may not correct that concern—does added volume address the concern you see?

    That distinction cannot be settled by a cup-size goal, a photograph, or general information. An individualized examination is needed to determine whether a lift belongs in the discussion—would you be open to a different approach if it better matched your anatomy?

    Breast revision is a separate consideration for someone with existing implants. It may involve revising, replacing, or removing implants; some cases involve replacement alone, while others require work on soft tissue or breast structure—if you have implants, what change are you trying to evaluate now?

    This first decision is not about choosing a procedure from a list. It is about naming the concern clearly enough to understand whether volume, breast position, or an existing implant result is central—can you state that concern without assuming the answer in advance?

    What Your Starting Anatomy Can and Cannot Answer

    A desired size is useful information, but it cannot determine a surgical plan by itself. During a consultation, you can discuss your goals and concerns, and recommendations may take your medical history and other factors into account—what would make a proposed size feel proportionate to you?

    Bring attention to your starting point: breast width, existing volume, the amount of natural tissue coverage, skin quality, and baseline differences between the breasts. Natural tissue coverage is one consideration when discussing placement, while pre-existing asymmetry may remain after surgery even with careful planning—have you considered which differences you would accept as part of your own anatomy?

    Body proportion and lifestyle also belong in the conversation. For an active patient, exercise and possible muscle interference can be discussion points when considering placement, so your work, training, childcare, and everyday movement are relevant planning details—what activities would you want to protect during recovery and afterward?

    A useful consultation does not promise an identical result to an image or another person’s outcome. Instead, it asks whether your goals, expectations, and motivation align with what surgery can reasonably aim to achieve—can you describe your priorities in terms of balance and proportion rather than a single measurement?

    Decision Two: Weigh Implant Features Only After Defining the Goal

    Once the change being considered is clear, implant features can be considered in context. In the United States, breast implants are FDA-approved devices for augmentation and reconstruction—what information would help you understand the device decision?

    Implants may be saline-filled or silicone-filled, and both have an outer silicone shell. Silicone implants contain cohesive gel, while saline implants are filled with sterile saltwater after placement and may feel firmer; neither option is universally better because anatomy, preferences, and goals matter—what trade-off matters most to you?

    A proposed size, shape, or profile has meaning only in relation to the volume goal and the breast that will support it. Ask for an explanation of how breast width, tissue coverage, body proportion, and desired change informed the recommendation—would the reasoning make sense without relying on a generic ideal?

    Placement, surface, and incision location also belong to the clinical discussion. For someone with little natural breast tissue, submuscular placement may be discussed as a way to help conceal implant edges, but no single feature determines the entire plan—does the proposed approach account for the limits as well as the intended change?

    Decision Three: Consider the Long-Term Device Commitment

    Recovery is not a single standard timetable. Timing varies by procedure, medical history, and other individual factors, so ask how recovery could affect work, childcare, exercise, sleep arrangements, transportation, and the activities that matter in your day-to-day life—who could support you while you recover?

    Implants are not lifetime devices, and future surgery to replace one or both implants may be needed. Pregnancy, weight loss, and menopause may also influence the appearance of augmented breasts over time, which is why the decision is about more than the immediate surgical result—are you comfortable considering the longer arc of this choice?

    For silicone implants, discuss the current FDA-recommended MRI or ultrasound screening schedule with a qualified clinician: five to six years after placement and every two to three years thereafter. Routine screening can assess implant integrity and identify rupture or silicone leakage, and rupture may be asymptomatic for some women—have you included future screening in your planning?

    This is general educational information, not a personal monitoring plan. Ask the clinician who knows your health history and implant details how follow-up, routine breast health care, and implant screening should fit together—do you know which follow-up questions you would want answered before proceeding?

    A practical way to assess the long-term commitment is to separate three responsibilities: keeping scheduled follow-up discussions, maintaining routine breast health care, and understanding when implant screening may be relevant. This does not mean every future change requires surgery, but it does mean the initial decision should leave room for future evaluation if your priorities, breast appearance, or implant condition changes—would you be prepared to revisit the plan if circumstances change over time?

    Monitoring is different from waiting until you notice a problem. Because rupture may be asymptomatic for some women, follow-up discussions can help you understand how implant integrity may be evaluated even when you do not notice a change; for silicone implants, ask who will help you keep track of the current FDA-recommended imaging schedule—would you be able to keep that information accessible over time?

    It can also help to regard a future implant discussion as an evaluation rather than a predetermined outcome. A later conversation may be relevant after a complication, a change in breast appearance, or a change in your own priorities, and the appropriate next step depends on the reason and an individualized assessment—does this longer perspective fit your expectations for an elective device decision?

    Understand the Uncertainty That Remains With Any Plan

    A plan can be carefully individualized and still involve uncertainty. Potential surgical and implant-related complications include anesthesia-related risks, bleeding, infection, fluid collections, hematoma, sensation changes, capsular contracture, leakage or rupture, implant malposition, persistent pain, poor scarring, and possible revision surgery—what uncertainties would be most important for you to understand?

    BIA-ALCL is a type of T-cell lymphoma that can develop following breast implants. FDA materials state that it appears more often in patients with textured implants, making the surface of a proposed device an important topic for a current discussion—would you want to understand the safety information for the device being considered?

    Breast implants and breast surgery may interfere with successful breastfeeding. Sensation changes may be temporary or permanent and may affect sexual response or nursing, while implants can interfere with mammography and breast exams; patients should tell their mammography technician about implants—how do these considerations relate to your present or future priorities?

    Implant removal can also change breast appearance, including size or shape, dimpling, puckering, sagging, chest-wall concavity, or incision appearance. These possibilities do not predict an individual outcome, but they show why the device decision includes more than the initial operation—does knowing the range of future possibilities change how you view the decision?

    Baseline asymmetry may remain after surgery, and implant displacement can contribute to asymmetry or other cosmetic concerns. A proposed plan cannot erase every variable, so realistic expectations should include what may remain outside a surgeon’s control—can you distinguish a planning goal from an assured appearance?

    Use the Three Decisions to Decide Whether to Continue

    Write down questions before your consultation. The answers may help you clarify or refine your goals, especially when you feel pulled between a desired look, practical recovery needs, and uncertainty about future surgery—what do you need to understand to make an unhurried decision?

    Use this list to connect the proposed plan to your priorities:

    • What are your qualifications in plastic surgery, and where would the procedure be performed?
    • What about my breast anatomy, tissue coverage, skin quality, asymmetry, and body proportion supports this recommendation?
    • Why are you recommending this implant fill, size, shape, profile, surface, incision, and placement for me?
    • What realistic expectations should I have, including differences that may remain after surgery?
    • How might recovery affect work, childcare, exercise, and other usual responsibilities?
    • What are the important risks in my situation, and how are complications handled?
    • How could surgery affect breastfeeding, nipple or breast sensation, mammography, and routine breast care?
    • What follow-up and silicone-implant screening discussions should I plan for?
    • What future surgeries might become relevant, and what are my options if I am dissatisfied?

    A surgeon should be able to explain the reasoning behind a recommendation in language you understand. If an answer does not connect the plan to your stated goals and practical circumstances, ask for clarification before deciding—can you repeat back the plan and why it was chosen?

    A mind map of consultation questions covering qualifications, anatomy and planning, implant choices, expectations and recovery, and safety and follow-up.
    A consultation should connect each recommendation to your anatomy, goals, recovery needs, and long-term planning.

    Make the Next Decision With Context

    General guidance can help you organize questions, but it cannot determine candidacy or select an implant, placement, lift, or breast revision for you. Those decisions require an individualized discussion of your goals, health history, anatomy, realistic expectations, recovery responsibilities, and comfort with long-term device considerations—are you ready to have that conversation with the full context in view?

    If you are considering this procedure in Beverly Hills, bring your priorities, questions, and concerns to a consultation with Dr. Golshani. If a virtual consultation would be more practical, confirm directly whether it is available and appropriate for your situation—would a focused first discussion help you decide whether to move forward?


    Frequently Asked Questions About Breast Augmentation Planning

    What is breast augmentation intended to change?

    It is surgery used to add breast volume, usually with implants and less often with fat transfer. The goal is typically a change in size and proportion, not a promise of a specific look.

    How do implant size, shape, and placement get chosen?

    Those choices are individualized to your breast width, tissue coverage, skin quality, asymmetry, body proportion, and lifestyle. Your surgeon should explain why a particular combination is being suggested for you.

    What should I ask about recovery before deciding on surgery?

    Ask how recovery may affect work, childcare, exercise, sleep, and daily support needs. Recovery timing varies by procedure and by patient, so it helps to plan around your real schedule instead of a generic timeline.

    What long-term issues should I understand before getting implants?

    Implants are not lifetime devices, and future surgery may be needed. You should also understand routine monitoring, possible implant rupture or leakage, changes in sensation, breastfeeding impact, and the chance that revision surgery could become relevant later.

    What questions should I bring to a breast augmentation consultation?

    Ask about qualifications, the proposed surgical plan, realistic expectations, risks, complication management, follow-up, and how the plan fits your anatomy and goals. Good answers should connect each recommendation to a clear reason.


  • Breast Augmentation Decision Guide: Goals, Trade-Offs, and Revision Questions

    Breast Augmentation Decision Guide: Goals, Trade-Offs, and Revision Questions

    Decide What You Want Breast Augmentation to Address

    It can use breast implants or fat transfer to increase breast size. People may consider it to restore volume after weight reduction or pregnancy, create a rounder shape, or address natural differences in breast size. The first decision is therefore not simply which implant to choose. It is whether the change you want is primarily about volume, shape, asymmetry, or a combination of concerns.

    A useful consultation begins with a short written description of your goal. For example: “I want more upper-breast fullness,” “I want to restore volume after pregnancy,” or “I want to address asymmetry.” Avoid treating a desired cup size as the entire plan; your surgeon will need to relate your goal to your anatomy, available tissue, and the procedure options that may be appropriate for you.

    This guide is for preparing questions, not determining candidacy or selecting treatment. Bring your goals, concerns, and willingness to accept long-term responsibilities to a qualified plastic surgeon. The discussion should cover both the appearance you hope to change and the trade-offs involved in achieving it.

    Test Your Goal Against the Procedure’s Limits

    Augmentation is not a universal solution for every breast-shape concern. Breast augmentation does not correct severely drooping breasts. When sagging is a significant part of the concern, a surgeon may discuss whether a breast lift should be performed alongside augmentation.

    This distinction matters because adding volume and lifting the breast address different aspects of appearance. If your main concern is loss of fullness, augmentation may be the central topic. If your concern is that the breast sits lower, the nipple position has changed, or the skin envelope feels substantially stretched, ask directly whether augmentation alone addresses that concern. Do not assume that a larger implant will substitute for a lift.

    Use these questions to define the boundary of your goal:

    • Is my primary concern volume, shape, asymmetry, sagging, or several of these?
    • Would augmentation alone address the concern I am describing?
    • Should a breast lift be discussed, and if so, how would that change the procedure and its trade-offs?
    • Would fat transfer be relevant to my stated goal, or is an implant discussion more appropriate?

    The practical next step is to ask the surgeon to separate what augmentation may address from what it cannot address by itself. That keeps the consultation focused on your actual concern rather than on a presumed procedure.

    Build Your Goals, Trade-Offs, and Long-Term Responsibilities Worksheet

    Bring a two-part worksheet to the consultation. The first part connects your desired change to surgical planning. The second addresses the responsibilities that continue after surgery.

    Part one: goals and planning

    Write down the change you want, how subtle or noticeable you want it to be, and any concerns about symmetry, shape, scars, or future activity. Then ask:

    • What options could address my goal: implants, fat transfer, augmentation with a lift, or another approach?
    • How do my anatomy and body type affect the available options?
    • What implant characteristics, if any, should we compare, and what are their relevant benefits and risks?
    • Where would an incision be considered, and how does incision planning relate to implant type, desired enlargement, anatomy, and surgeon preference?
    • How would implant insertion and positioning be planned for my body type and desired enlargement?
    • What recovery restrictions and follow-up visits should I plan for, and which aspects of recovery are individualized?

    Incision planning varies with the implant type, the enlargement sought, anatomy, and patient-surgeon preference. Implant placement planning likewise depends on the implant, desired enlargement, body type, and the surgeon’s recommendations. These are consultation decisions, not choices that can be made responsibly from a general guide.

    Part two: long-term responsibilities

    Add questions about device-specific labeling, monitoring, breast-cancer screening, possible reoperation, and financial responsibility. Ask the surgeon to identify which recommendations apply to the implant option under discussion and what costs may arise over time.

    Before deciding, review the manufacturer’s patient labeling and educational materials, and discuss questions with the surgeon. In the United States, the FDA requires a device-specific Patient Decision Checklist describing known or reported risks. Ask to review the checklist for the specific device being considered, rather than relying on general descriptions of implants.

    The worksheet is complete when you can explain your goal, the planning variables that may affect the procedure, the risks you have discussed, the follow-up you may need, and the questions you still want answered. It is a preparation tool, not a prediction of your result or recovery.

    Weigh Risks, Financial Responsibilities, and Possible Future Surgery

    The central long-term trade-off is that breast implants are not lifetime devices. FDA says that the longer implants are in place, the more likely removal or replacement becomes, and advises prospective patients to assume that additional operations may be needed over time. That possibility should be part of the decision before an initial procedure, not considered only if a problem develops.

    FDA identifies capsular contracture, reoperation, and implant removal among the most common local complications and adverse outcomes. Other listed local complications include rupture or deflation, wrinkling, asymmetry, scarring, pain, and infection at the incision site. The list describes possible complications, not a prediction that any particular patient will experience them.

    Financial planning also belongs in the risk discussion. FDA notes that insurance may not cover implant removal or replacement, including when complications occur. Ask for a clear explanation of anticipated surgical, facility, anesthesia, device, imaging, medication, and follow-up costs. Ask separately what happens financially if an implant must be removed, replaced, or revised.

    A responsible decision does not require certainty that every future event can be predicted. It does require accepting that implants may involve future monitoring, complications, additional operations, and expenses.

    Plan for Monitoring, Screening, and Changes That Need Evaluation

    Implants need monitoring for as long as they remain in place. If silicone gel-filled implants are being considered, confirm with your health care provider whether regular ultrasound or MRI monitoring is recommended and whether that monitoring is covered by insurance. The appropriate schedule and imaging decisions should come from your health care provider.

    Breast implants also affect how you communicate about breast-cancer screening. Follow your provider’s instructions for screening and tell the mammography facility that you have implants when making an appointment. Clarify with the facility what to expect for mammography with implants.

    Make a plan for contacting a surgeon or other health care provider if you notice abnormal changes in your breasts or implants.
    These points are not an emergency diagnosis or a substitute for medical evaluation. They are questions to place in your long-term-responsibility section:

    • What monitoring do you recommend for the specific implant being discussed?
    • How should I coordinate implant monitoring with breast-cancer screening?
    • What changes should prompt a call, and whom should I contact?
    • What imaging, evaluation, or follow-up costs should I anticipate?

    Leave the consultation with a written follow-up plan and a clear route for raising concerns.

    Review Device-Specific Information Before You Decide

    Implant decisions should be based on the labeling and risk information for the specific device under consideration. Review the manufacturer’s patient labeling and educational materials, then discuss questions with the surgeon before deciding. The Patient Decision Checklist is intended to support that discussion by presenting known or reported risks for the device.

    One risk that should be addressed directly is BIA-ALCL. FDA describes it as a cancer of the immune system that can occur in the breast or scar tissue surrounding an implant; it is not breast cancer. ASPS notes that BIA-ALCL occurs most frequently in patients with textured-surface implants. Ask which implant surfaces and characteristics are being considered, why, and what information applies to each option.

    Useful questions include:

    • Can I review the manufacturer’s current patient labeling for this device?
    • Can we go through the device-specific Patient Decision Checklist together?
    • What is known about the device’s surface, rupture or deflation concerns, monitoring, and possible reoperation?
    • What symptoms or changes should lead me to contact the practice?
    • Which risks are specific to this device, and which are general surgical risks?

    The goal is not to memorize every complication. It is to understand the device-specific information well enough to make a deliberate decision and to know what follow-up responsibilities may continue after surgery.

    Confirm the Stated Revision Assurance Terms in Writing

    Golshani Plastic Surgery states that a 90-day Revision Assurance Program is available for breast augmentation at its Beverly Hills location. The stated terms limit it to primary procedures performed at that office, not procedures performed elsewhere or by another surgeon. The practice also states that patients dissatisfied within 90 days of the original surgery date may be eligible for one revision and that the standard surgeon’s fee is waived.

    Treat these as practice-stated terms that require current written confirmation. The supplied policy information does not establish that every revision-related expense is covered. In particular, do not assume that facility, anesthesia, implant, medication, pathology, imaging, or other costs are included in the surgeon-fee waiver.

    Ask these questions before relying on the program in your decision:

    • Is the program currently effective, and can I receive the complete written policy?
    • Does it apply to my planned primary procedure at the Beverly Hills office?
    • How is the 90-day period calculated, and what notice or evaluation process is required?
    • What does “one revision” mean, and who determines whether a revision is indicated or eligible?
    • Does the waiver cover only the standard surgeon’s fee?
    • Which facility, anesthesia, implant, medication, pathology, imaging, or other costs remain my responsibility?
    • What exclusions, circumstances, timing requirements, or documentation rules apply?
    • What happens if I receive care at another location or from another surgeon?

    The program should be one item in a broader decision, not a substitute for risk counseling or a guarantee of a particular aesthetic result, satisfaction, candidacy, or coverage. Obtain the current terms and exclusions in writing during consultation.

    Make a More Informed Consultation Decision

    This procedure may align with your goals if you can clearly describe the change you want and are prepared to discuss its limits, planning variables, risks, monitoring, possible future operations, and financial responsibilities. A consultation is a reasonable next step when you want individualized answers—but it should leave you with informed questions, not pressure to decide immediately.

    Bring the completed worksheet, manufacturer information, and the written questions about the stated Revision Assurance Program. Use the consultation to determine whether the proposed approach addresses your concern, what trade-offs it involves, and which terms and follow-up responsibilities apply to you. A consultation can support individualized discussion, but it does not guarantee candidacy, outcomes, safety, satisfaction, or eligibility for revision coverage.


    Frequently Asked Questions About Preparing for Breast Augmentation

    What does breast augmentation involve?

    It is a procedure that uses breast implants or fat transfer to increase breast size.

    How do surgeons decide between implants, fat transfer, or a lift?

    That depends on the change you want, your anatomy, and the concern being addressed. If sagging is a major issue, a surgeon may discuss whether a breast lift should be part of the plan rather than augmentation alone.

    Are breast implants considered permanent?

    No. FDA states that breast implants are not lifetime devices, so additional surgery may be needed over time. The possibility of removal or replacement should be part of the decision from the start.

    What follow-up is usually discussed after breast augmentation?

    Follow-up usually includes ongoing monitoring while implants are in place, plus guidance on screening and what changes should prompt a call. If silicone gel-filled implants are being considered, ask whether ultrasound or MRI monitoring is recommended and how it is handled.

    What should I clarify about the Beverly Hills revision program?

    Ask for the current written terms and confirm whether the program applies to a primary procedure at that office. Also clarify the 90-day window, the one-revision limit, whether only the surgeon’s fee is waived, and which other costs would still be your responsibility.